info@mail.ucallm.com
From Metabolic Pathway Remodeling to Immune Cell Function — Empowering Comprehensive Investigation of Cellular Metabolism, Immune Activation & Disease-Associated Metabolic Adaptation
Immune cell function is tightly controlled by dynamic metabolic programs that determine cellular activation, differentiation, proliferation, effector function, and adaptation to environmental stress.
Immunometabolism represents the intersection between metabolic pathways and immune regulation, where nutrients, metabolites, and signaling networks collectively shape immune cell fate and function.
Metabolic reprogramming regulates key immune processes, including:
Glucose uptake and glycolytic activation
Mitochondrial respiration and oxidative phosphorylation
Fatty acid synthesis and lipid oxidation
Amino acid metabolism and biosynthetic pathways
Redox homeostasis and oxidative stress adaptation
Nutrient sensing and metabolic signaling
Immune cell differentiation and functional polarization
Activated immune cells undergo profound metabolic remodeling to meet increased energetic and biosynthetic demands. Dysregulated immunometabolic pathways contribute to diverse pathological conditions, including:
Cancer progression and immune evasion
Chronic inflammation and autoimmune disorders
Metabolic syndrome and obesity-associated inflammation
Fibrosis and tissue remodeling
Infectious disease responses
Immune aging and functional decline
Our validated antibody solutions enable researchers to move beyond individual metabolic markers toward integrated profiling of metabolic pathways, signaling networks, immune cell states, and disease-associated metabolic adaptation.
Immunometabolism Antibody Portfolio
—Comprehensive Solutions for Profiling Metabolic Reprogramming, Immune Activation & Disease-Associated Functional States
Immune metabolism is governed not only by metabolic enzyme expression, but also by coordinated regulation of:
Metabolic pathway activity
Mitochondrial function and bioenergetics
Nutrient sensing pathways
Transcriptional metabolic regulation
Redox balance and stress responses
Cell-type specific metabolic adaptation
Research Focus | Representative Targets | Biological Interpretation & Research Applications |
Glucose Uptake & Glycolytic Reprogramming | GLUT1/SLC2A1 , HK1 , HK2 , PFKFB3 , GAPDH , PKM/PKM2 , LDHA , PDHA1 , PDK1 | Characterizes glucose transport, glycolytic activation, lactate production, and metabolic switching during immune activation, inflammation, and tumor-associated immune responses |
Mitochondrial Metabolism & Oxidative Phosphorylation | Citrate Synthase (CS) , SDHA/SDHB , IDH2 , OGDH , GLUD1 , CYCS , ATP5A | Evaluates mitochondrial metabolic capacity, TCA cycle activity, electron transport, ATP production, and mitochondrial adaptation during immune-cell activation |
Fatty Acid Metabolism & Lipid Remodeling | CD36 , CPT1A , ACACA/ACC1 , FASN , ACLY , SREBP1 , DGAT1 | Investigates lipid uptake, fatty acid oxidation, de novo lipogenesis, and lipid storage pathways associated with immune differentiation and functional specialization |
Amino Acid Metabolism & Biosynthetic Regulation | GLS1 , GLUD1 , ARG1 , ARG2 , NOS2/iNOS , ASS1 , SHMT2 | Profiles glutamine metabolism, arginine metabolism, nitric oxide production, one-carbon metabolism, and biosynthetic programs supporting immune-cell function |
Metabolic Sensing & Signaling Networks | AMPKα , p-AMPKα Thr172, mTOR, Raptor , Rictor , PI3K p110α , PI3K p85 , pan-AKT, p-AKT Thr308, p-AKT Ser473, HIF-1α, MYC, PPARG, NR4A1, NR1D1 | Connects nutrient sensing, growth signaling, hypoxia adaptation, transcriptional regulation, and metabolic programming with immune-cell activation and differentiation |
Hypoxia & Glycolytic Adaptation | HIF-1α , PDK1 , GLUT1 , LDHA , PKM2,, CA9, VHL | Defines hypoxia-driven metabolic remodeling and glycolytic adaptation in tumors, inflamed tissues, and immune microenvironments |
Pentose Phosphate Pathway & Redox Regulation | G6PD , TKT , TIGAR , NRF2/NFE2L2 , SOD2 , GPX4 | Investigates NADPH production, antioxidant defense, ROS regulation, lipid peroxidation control, and cellular stress adaptation |
Macrophage Immunometabolic Programming | ARG1 , NOS2/iNOS , PPARγ , PPARδ , HIF-1α , mTOR , AMPK | Characterizes metabolic programs associated with macrophage polarization, inflammatory activation, tissue repair, and tumor-associated macrophage states |
T Cell & Immune Effector Metabolism | mTOR , AMPK , MYC , GLUT1 , HK2 , CPT1A , PGC-1α | Studies metabolic requirements underlying T-cell activation, differentiation, exhaustion, memory formation, and immune therapy responses |
Immunometabolic Regulatory Network
—Master Regulatory Programs Linking Metabolic State to Immune Cell Function
Immune-cell function is not determined solely by metabolic pathway activity, but by dynamic regulatory networks that sense energy availability, oxygen tension, nutrient abundance, and environmental stress.
These regulatory circuits integrate intracellular signaling, transcriptional programs, and epigenetic mechanisms to control:
- Immune-cell activation and differentiation
- Inflammatory versus regulatory functional states
- Metabolic adaptation within tissues and tumors
- Mitochondrial fitness and redox homeostasis
- Long-term immune memory and functional remodeling
Our antibody solutions enable comprehensive profiling of immunometabolic regulation from:
Regulatory Network | Representative Targets | Biological Interpretation & Research Applications |
AMPK Energy-Sensing & Metabolic Adaptation Network | AMPK/PRKAA1 , p-AMPK , SIRT1 , PGC-1α , FOXO1 | Master cellular energy sensor regulating ATP homeostasis, mitochondrial biogenesis, fatty acid oxidation, autophagy, and metabolic adaptation during nutrient limitation and immune stress responses. |
mTOR Nutrient-Sensing & Anabolic Regulation Network | mTOR , p-mTOR , Raptor , Rictor , AKT , PI3K | Central metabolic checkpoint integrating amino acids, growth signals, and nutrient availability to regulate protein synthesis, cellular growth, immune activation, and differentiation. |
PI3K–AKT Survival & Metabolic Activation Network | PI3K , AKT , p-AKT , FOXO1 , GSK3β , GLUT1 | Links extracellular signals with glucose uptake, survival pathways, metabolic remodeling, and immune-cell functional activation. |
Hypoxia & HIF-1α Metabolic Adaptation Network | HIF-1α , p-HIF-1α , VHL , PDK1 , LDHA , GLUT1 | Controls oxygen sensing, glycolytic reprogramming, inflammatory metabolism, and immune adaptation within hypoxic tissues and tumor microenvironments. |
MYC-Driven Biosynthetic & Metabolic Programming Network | MYC , MAX , GLUT1 , HK2 , PFKFB3 , LDHA | Promotes metabolic activation, glycolysis, nucleotide biosynthesis, biomass production, and immune-cell proliferation during activation and expansion. |
PPAR Nuclear Receptor Metabolic Network | PPARγ , PPARα , PPARδ , RXRα , LXRα | Regulates lipid sensing, fatty acid metabolism, macrophage functional polarization, tissue adaptation, and immunometabolic differentiation programs. |
NR4A Immune Homeostasis & Functional State Network | NR4A1 , NR4A2 , NR4A3 | Controls immune-cell homeostasis, macrophage identity, metabolic adaptation, inflammatory regulation, and tissue-specific immune responses. |
NRF2–KEAP1 Antioxidant & Redox Regulation Network | NRF2/NFE2L2 , KEAP1 , G6PD , SOD2 , GPX4 , HO-1 | Maintains oxidative balance through antioxidant defense, NADPH generation, ROS control, and protection against metabolic stress-induced dysfunction. |
Sirtuin & Epigenetic Metabolic Regulation Network | SIRT1 , SIRT3 , HDAC1, HDAC2, HDAC3 , DNMT1 , TET2 , EZH2 | Connects metabolic intermediates with chromatin remodeling, transcriptional memory, immune-cell differentiation, and inflammatory gene regulation. |
Integrated Immunometabolic Reprogramming Network | AMPK , mTOR , HIF-1α , PPARγ , NRF2 , MYC | Represents the convergence of metabolic sensing pathways controlling immune-cell fate decisions, including inflammatory activation, immune suppression, exhaustion, and tissue adaptation. |
Featured Immunometabolism Research Panels
—Comprehensive Antibody Panels for Mapping Metabolic Remodeling, Immune Activation & Disease Mechanisms
Immunometabolic phenotypes emerge from coordinated changes in nutrient utilization, metabolic flux, signaling activity, mitochondrial function, lipid metabolism, and redox homeostasis.
These focused panels enable multiparametric profiling of metabolic programs underlying immune-cell activation, differentiation, adaptation, and dysfunction.
n Glycolytic Activation & Immune Effector Metabolism Panel—Define metabolic switching during immune activation
GLUT1 | HK2 | PFKFB3 | PKM2 | LDHA | HIF-1α | PDK1 |
n Mitochondrial Function & Bioenergetics Panel—Characterize mitochondrial metabolic capacity and oxidative phosphorylation
CS | SDHA/SDHB | IDH2 | CYCS | ATP5A | PGC-1α | OGDH |
n Lipid Metabolism & Macrophage Functional Programming Panel—Investigate lipid-associated immune regulation
CD36 | CPT1A | FASN | ACC1 | SREBP1 | PPARγ | ACLY |
n Immunometabolic Signaling Regulation Panel—Connect metabolic pathways with immune signaling networks
AMPK | p-AMPK | mTOR | p-mTOR | AKT | HIF-1α | MYC |
n Redox Homeostasis & Metabolic Stress Panel—Analyze oxidative stress responses and metabolic stability
NRF2 | G6PD | SOD2 | GPX4 | TIGAR |
n Amino Acid & One-Carbon Metabolism Panel—Characterize amino acid utilization and biosynthetic pathways supporting immune-cell function
GLS1 | GLUD1 | ARG1 | ARG2 | ASS1 | NOS2/iNOS | SHMT2 | SLC1A5 |
Why Researchers Choose Our Immunometabolism Research Solutions
Integrated Antibody Solutions for Mapping Metabolic Pathways, Immune Function & Disease Adaptation
Immunometabolism requires multidimensional characterization beyond measuring individual metabolic enzymes.
Our validated antibody portfolio enables researchers to investigate:
Research Question | Integrated Antibody Solution |
How do immune cells reprogram their metabolism during activation? | Glycolytic and metabolic pathway profiling — GLUT1, HK2, PKM2, LDHA combined with signaling regulators |
How is mitochondrial function altered during immune responses? | Bioenergetic profiling — TCA cycle enzymes, oxidative phosphorylation markers, mitochondrial regulators |
How do metabolic pathways regulate immune-cell fate? | Metabolic signaling analysis — AMPK, mTOR, AKT, MYC, HIF-1α pathway profiling |
How does metabolism influence macrophage polarization? | Immunometabolic profiling — ARG1, NOS2, PPARγ, HIF-1α, mTOR and AMPK signaling |
How do tumors reshape immune metabolism? | Tumor immunometabolism profiling — glycolysis, lipid metabolism, hypoxia, and immune checkpoint-associated pathways |
How can metabolic mechanisms be spatially characterized? | Multiplex IF/IHC-based metabolic profiling to visualize metabolic states within tissue microenvironments |
Key reference
1. Su R, Shao Y, Huang M, Liu D, Yu H, Qiu Y. Immunometabolism in cancer: basic mechanisms and new targeting strategy. Cell Death Discov. 2024 May 16;10(1):236.
2. Zhang H, Fan J, Kong D, Sun Y, Zhang Q, Xiang R, Lu S, Yang W, Feng L, Zhang H. Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy. Mol Cancer. 2025 Oct 8;24(1):249.
3. Voss K, Hong HS, Bader JE, Sugiura A, Lyssiotis CA, Rathmell JC. A guide to interrogating immunometabolism. Nat Rev Immunol. 2021 Oct;21(10):637-652.
4. Viel S, Vivier E, Walzer T, Marçais A. Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer. Nat Rev Drug Discov. 2025 Mar;24(3):190-208.
5. DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol. 2021 Dec;21(12):785-797.
6. Reina-Campos M, Scharping NE, Goldrath AW. CD8+ T cell metabolism in infection and cancer. Nat Rev Immunol. 2021 Nov;21(11):718-738.
7. Li J, Guo C, Yang X, Xie W, Mi W, Hua C, Tang C, Wang H. Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases. Pharmacol Res. 2025 Mar;213:107634.